The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Systematic review of risk and protective factors associated with substance use and abuse in individuals with autism spectrum disorders
Abstract
A systematic review of autism spectrum disorder and substance use and abuse was conducted based on the Preferred Reporting Items for Systematic Review and Meta-Analysis protocol guidelines (an internationally recognized standardized methodological framework for conducting systematic review). The objectives of the review were to update and extend findings reported by Arnevik and Helverschou’s review of the autism spectrum disorder and substance use literature by (1) evaluating study quality via the Mixed-Methods Appraisal Tool; (2) examining autism spectrum disorder and substance abuse diagnostic measures; (3) reporting on the prevalence of co-occurring autism spectrum disorder and substance abuse; and (4) identifying risk, protective, and positive treatment factors. Twenty-six studies on substance use and abuse in autism spectrum disorder were identified through a search of MEDLINE, PsycINFO and Google Scholar. Average study quality score was 75.4%. Prevalence rates of substance abuse among samples with autism spectrum disorder ranged from 1.3% to 36%, but due to variability in sample characteristics and diagnostic measures, a general prevalence rate could not be established. Risk and protective factors, recognized in the general population, such as familial substance abuse and comorbid externalizing disorders, and factors, which may be more likely to occur in individuals with autism spectrum disorder compared to the general population, such as few social resources (i.e. sense of social belonging, breadth of social support networks, and level of social capital) and low sensation-seeking, were identified. One intervention study was identified; however, methodological limitations preclude any conclusion regarding positive treatment factors at this time. More research, using standardized measures and comparable samples, is needed to understand risk and protective factors and to determine the prevalence of co-occurring substance abuse and autism spectrum disorder. Lay Abstract: Symptoms characteristic of autism spectrum disorder were initially believed to protect individuals with autism spectrum disorder from developing substance abuse. However, recent studies suggest that up to 36% of individuals with autism spectrum disorder may have a co-occurring issue with substance abuse. In addition, substance abuse may worsen the difficulties with daily functioning some individuals with autism spectrum disorder experience. It is important to understand occurrence rates, and risk, protective and positive treatment factors of co-occurring autism spectrum disorder and substance abuse in order to promote the best possible support for this special population. This review aimed to find and synthesize evidence regarding risk, protective and treatment factors, and determine a general prevalence rate of co-occurring autism spectrum disorder and substance abuse from all studies on substance use and abuse in individuals with autism spectrum disorder. The review also aimed to assess study quality and identify a diagnostic measure for substance abuse in individuals with autism spectrum disorder. Twenty-six studies on substance use and abuse in autism spectrum disorder were included in the review. The rates of substance abuse among those with autism spectrum disorder identified by included studies ranged from 1.3% to 36%, but due to large differences in study methods, a general prevalence rate could not be determined. Risk and protective factors, recognized in the general population, such as familial substance abuse and co-occurring mental health issues, and factors which may be more likely to occur in individuals with autism spectrum disorder, such as limited social resources and low sensation-seeking, were identified. No diagnostic measures specific to individuals with autism spectrum disorder and substance abuse were identified. This review identified only one exploratory study on an adapted intervention for co-occurring autism spectrum disorder and substance abuse. However, there were many methodological challenges in this study that limit the conclusions that can be drawn from the data. More research, using consistent methods, is needed to understand risk and protective factors and to determine the prevalence of substance abuse among individuals with autism spectrum disorder. The potential for co-occurring autism spectrum disorder and substance abuse should be considered by professional working in both autism spectrum disorder and substance abuse services, as finding suggests substance abuse is possible among individuals with autism spectrum disorder and may occur more frequently than previously believed. In addition, autism spectrum disorder and substance abuse service providers should be sensitive to specific risk and protective factors identified by the review that may impact substance abuse course and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242 · cited 2×
“Consistent with the self-medication hypothesis, which proposes that a substance is used for its psychoactive properties that subjectively diminish psychological distress and increase cognitive control (Khantzian, 1997), our findings suggest that both psychological distress and executive functioning deficits increase t…”
BackgroundResultKendler, K. S., Prescott, C. A., Myers, J., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.929 · Cited by 1,868 · cited 3×
“ADHD, oppositional defiance disorders) (Kendler et al., 2003).”
Pace, R., Pluye, P., Bartlett, G., Macaulay, A. C., Salsberg, J., Jagosh, J., & Seller, R. (2012) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.07.002 · Cited by 1,331
Hong, Q. N., Gonzalez‐Reyes, A., & Pluye, P. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12884 · Cited by 1,107 · cited 5×
“See Hong et al. (2018) for a description of study criteria relevant to each study design.”
BackgroundMethodInfluentialPsychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders
Hofvander, B., Delorme, R., Chaste, P., Nydén, A., Wentz, E., Ståhlberg, O., Herbrecht, E., Stopin, A., Anckarsäter, H., Gillberg, C., et al. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-35 · Cited by 812
Brown, S. A., Christiansen, B. A., & Goldman, M. S. (1987) · Journal of Studies on Alcohol · doi:10.15288/jsa.1987.48.483 · Cited by 803
Systematic reviews and meta-analysis: Understanding the best evidence in primary healthcare
Ganeshkumar, P., & Gopalakrishnan, S. (2013) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.109934 · Cited by 743
Wing, L., Leekam, S. R., Libby, S. J., Gould, J., & Larcombe, M. (2002) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00023 · Cited by 694
Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity.
Armstrong, T. D., & Costello, E. J. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.6.1224 · Cited by 692
Peer interaction and loneliness in high-functioning children with autism
Bauminger, N., Shulman, C., & Agam, G. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025827427901 · Cited by 495 · cited 1×
“Young people and adults with ASD and average intelligence often experience loneliness and a desire for social interaction, but struggle to achieve it (Mazurek, 2014; Shulman & Agam, 2003), and substance use may be viewed as aiding social engagement.”
BackgroundPsychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome
Lugnegård, T., Hallerbäck, M. U., & Gillberg, C. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.03.025 · Cited by 483 · cited 2×
“Three studies examined factors that were found to be statistically non-significant (comorbid externalizing disorder; Brookman-Frazee et al., 2009; Lugnegärd et al., 2011; perceived social deficits and psychological distress; Helverschou et al., 2019).”
BackgroundAutism spectrum disorder: outcomes in adulthood
Howlin, P., & Magiati, I. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000308 · Cited by 457
Loneliness, friendship, and well-being in adults with autism spectrum disorders
Mazurek, M. O. (2014) · Autism · doi:10.1177/1362361312474121 · Cited by 401 · cited 1×
“Young people and adults with ASD and average intelligence often experience loneliness and a desire for social interaction, but struggle to achieve it (Mazurek, 2014; Shulman & Agam, 2003), and substance use may be viewed as aiding social engagement.”
BackgroundWhy prospective registration of systematic reviews makes sense
Stewart, L., Moher, D., & Shekelle, P. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-7 · Cited by 375
Ozonoff, S., South, M., & Miller, J. N. (2000) · Autism · doi:10.1177/1362361300004001003 · Cited by 286
Etiology of early age onset substance use disorder: A maturational perspective
TARTER, R., VANYUKOV, M., GIANCOLA, P., DAWES, M., BLACKSON, T., MEZZICH, A., & CLARK, D. B. (1999) · Development and Psychopathology · doi:10.1017/s0954579499002266 · Cited by 272
Caffeine Use Disorder: A Comprehensive Review and Research Agenda
Meredith, S. E., Juliano, L. M., Hughes, J. R., & Griffiths, R. R. (2013) · Journal of Caffeine Research · doi:10.1089/jcr.2013.0016 · Cited by 209
Butwicka, A., Långström, N., Larsson, H., Lundström, S., Serlachius, E., Almqvist, C., Frisén, L., & Lichtenstein, P. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-2914-2 · Cited by 185
Developments in the Epidemiology of Drug Use and Drug Use Disorders
Compton, W. M., Thomas, Y. F., Conway, K. P., & Colliver, J. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1494 · Cited by 178
Hildebrand, M. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.01.008 · Cited by 177 · cited 3×
“…reason for beginning substance use on a preintervention assessment of positive and negative aspects of substance intoxication via the Drug Use Disorder Identification Test–Extended (DUDIT-E; Hildebrand, 2015) and Alcohol Use Disorders Identification Test–Extended (AUDIT-E; Berner et al., 2007).”
MethodInfluentialLundström, S., Chang, Z., Kerekes, N., Gumpert, C. H., Råstam, M., Gillberg, C., Lichtenstein, P., & Anckarsäter, H. (2011) · Psychological Medicine · doi:10.1017/s0033291711000377 · Cited by 174
Biederman, J., Monuteaux, M. C., Mick, E., Wilens, T. E., Fontanella, J. A., Poetzl, K. M., Kirk, T., Masse, J., & Faraone, S. V. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.009 · Cited by 172
Health Conditions and Functional Status in Adults with Autism: A Cross-Sectional Evaluation
Fortuna, R. J., Robinson, L., Smith, T. H., Meccarello, J., Bullen, B., Nobis, K., & Davidson, P. W. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3509-x · Cited by 169
Berner, M. M., Kriston, L., Bentele, M., & Härter, M. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.461 · Cited by 165
Woodbury‐Smith, M., Clare, I. C. H., Holland, A. J., & Kearns, A. (2006) · Journal of Forensic Psychiatry and Psychology · doi:10.1080/14789940600589464 · Cited by 135
Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders
Biederman, J., Petty, C. R., Wilens, T. E., Fraire, M. G., Purcell, C. A., Mick, E., Monuteaux, M. C., & Faraone, S. V. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030419 · Cited by 114
Brookman-Frazee, L. I., Baker-Ericzén, M. J., Stahmer, A. C., Mandell, D. S., Haine, R. A., & Hough, R. L. (2009) · Journal of Mental Health Research in Intellectual Disabilities · doi:10.1080/19315860902741542 · Cited by 114
Sizoo, B. B., van den Brink, W., Koeter, M. W. J., Eenige, M. G.-V., van Wijngaarden-Cremers, P. J. M., & van der Gaag, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.09.003 · Cited by 111
Psychiatric comorbidities in autism spectrum disorders: findings from a Danish Historic Birth Cohort
Abdallah, M. W., Greaves-Lord, K., Grove, J., Nørgaard-Pedersen, B., Hougaard, D. M., & Mortensen, E. L. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0220-2 · Cited by 108
Mangerud, W. L., Bjerkeset, O. A., Holmen, T. L., Lydersen, S., & Indredavik, M. S. (2014) · Journal of Adolescence · doi:10.1016/j.adolescence.2014.08.007 · Cited by 106
Beyond childhood: psychiatric comorbidities and social background of adults with Asperger syndrome.
Roy, M., Prox-Vagedes, V., Ohlmeier, M. D., & Dillo, W. (2015) · PubMed · Cited by 90
Sizoo, B., van den Brink, W., van Eenige, M. G., & van der Gaag, R. J. (2009) · Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181a61dd0 · Cited by 88
Nylander, L., Holmqvist, M., Gustafson, L., & Gillberg, C. (2013) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2012.748824 · Cited by 81
ADHD Symptoms, Autistic Traits, and Substance Use and Misuse in Adult Australian Twins
Alwis, D. D., Agrawal, A., Reiersen, A. M., Constantino, J. N., Henders, A. K., Martin, N. G., & Lynskey, M. T. (2014) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2014.75.211 · Cited by 77
Autism Spectrum Disorder and Co-occurring Substance Use Disorder – A Systematic Review
Arnevik, E. A., & Helverschou, S. B. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s39921 · Cited by 73
Helverschou, S. B., Rasmussen, K. B., Steindal, K., Søndanaa, E., Nilsson, B., & Nøttestad, J. A. (2015) · Autism · doi:10.1177/1362361315584571 · Cited by 70
Kronenberg, L. M., Slager-Visscher, K., Goossens, P. J. J., van den Brink, W., & van Achterberg, T. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0264-1 · Cited by 68
Prevalence and correlates of autism in a state psychiatric hospital
Mandell, D. S., Lawer, L. J., Branch, K., Brodkin, E. S., Healey, K., Witalec, R., Johnson, D. N., & Gur, R. E. (2012) · Autism · doi:10.1177/1362361311412058 · Cited by 66
Esan, F., Chester, V., Gunaratna, I., Hoare, S., & Alexander, R. (2014) · Journal of Applied Research in Intellectual Disabilities · doi:10.1111/jar.12121 · Cited by 60
Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome
Ramos, M., Boada, L., Moreno, C., Llorente, C. D. M., Romo, J., & Parellada, M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.022 · Cited by 50
Ham, L. S. (2009) · Cognitive Therapy and Research · doi:10.1007/s10608-009-9248-8 · Cited by 49
Kronenberg, L. M., Goossens, P. J. J., van Busschbach, J. T., van Achterberg, T., & van den Brink, W. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0530-x · Cited by 47
Autism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?
Rothwell, P. E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00020 · Cited by 42
Lalanne, L., Weiner, L., Trojak, B., Berna, F. S., & Bertschy, G. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0541-7 · Cited by 37
Clarke, T., Tickle, A., & Gillott, A. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.06.003 · Cited by 36
Helverschou, S. B., Brunvold, A. R., & Arnevik, E. A. (2019) · Substance Abuse Research and Treatment · doi:10.1177/1178221819843291 · Cited by 36
Screening for autism spectrum disorder in adult psychiatric outpatients in a clinic in Taiwan
Chang, H., Juang, Y., Wang, W.-T., Huang, C., Chen, C.-Y., & Hwang, Y.-S. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(03)00053-7 · Cited by 35
Kronenberg, L. M., Goossens, P. J. J., van Etten, D. M., van Achterberg, T., & van den Brink, W. (2014) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12056 · Cited by 32
Kronenberg, L. M., Verkerk-Tamminga, R., Goossens, P. J. J., van den Brink, W., & van Achterberg, T. (2015) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2015.04.006 · Cited by 29
The Critical Lack of Data on Alcohol and Marijuana Use by Adolescents on the Autism Spectrum
Adhia, A., Bair‐Merritt, M. H., Broder‐Fingert, S., Nunez-Pepen, R., Suarez-Rocha, A. C., & Rothman, E. F. (2020) · Autism in Adulthood · doi:10.1089/aut.2019.0051 · Cited by 24
Mulligan, R. C., Reiersen, A. M., & Todorov, A. A. (2013) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2014-012 · Cited by 21
Addiction and Autism: A Remarkable Comorbidity?
van Wijngaarden-Cremers, P. J. M. (2014) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000170 · Cited by 19
Cigarette Smoking, Alcohol and Cannabis Use in Patients With Pervasive Developmental Disorders
Schapir, L., Lahav, T., Zalsman, G., Krivoy, A., Sever, J. M., Weizman, A., & Shoval, G. (2016) · Substance Use & Misuse · doi:10.3109/10826084.2016.1170146 · Cited by 10
Metadata
- Authors
- Ressel, M., Thompson, B., Poulin, M.-H., Normand, C. L., Fisher, M. H., Couture, G., & Iarocci, G.
- Venue
- Autism
- Publisher
- SAGE Publications
- Published
- 2020-05
- Volume
- 24
- Issue
- 4
- Pages
- 899-918
- ISSN
- 1362-3613 (ISSN-L)
- 1461-7005
- OpenAlex
- W3027457017
- Cited by
- 376
- References
- 56
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.